ISDA letter to ESMA and National Competent Authorities (NCAs) providing an update on anticipated challenges for EMIR reporting of OTC Derivatives from February 12, 2014.
Appendix 1: Update on each of the industry issues and challenges advised previously (Appendix 2).
Appendix 2: Original list of industry issues and challenges.
Documents (3) for ISDA letter to ESMA and NCAs on OTC challenges for EMIR reporting – update
Latest
ISDA AGM Studio: Jenny Cosco and Jason Granet
Jenny Cosco, global head of government relations and regulatory strategy at LSEG, and Jason Granet, chief investment officer at BNY, speak with Tara Kruse, ISDA’s global head of derivative products and infrastructure, about how firms can manage liquidity pressures during...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
Capital Models Benchmarking: A Framework for Counterparty Credit Risk Internal Models
When firms implement capital models in line with supervisory standards, a range of interpretative and implementation choices inevitably arise. These choices reflect differences in modeling approaches, data availability, system architecture and risk management practices, and can lead to variation in...
ISDA AGM Studio: Joana Schlenczek & Nate Wuerffel
Joana Schlenczek, ISDA board member and head of FI rates structuring and client solutions at Santander Corporate & Investment Banking, and Nate Wuerffel, global head of market structure and head of product, global collateral, at BNY, speak with Panayiotis Dionysopoulos,...